Lipid-Lowering, Antidiabetic Drugs Tied to Prevalence of AMD
TUESDAY, Nov. 8, 2022 (HealthDay News) — Lipid-lowering drugs (LLDs) and antidiabetic drugs are associated with lower prevalence of any age-related macular degeneration (AMD), according to a meta-analysis published online Nov. 7 in the British Journa…
Learn MoreCasi 20 millones de estadounidenses mayores viven con degeneración macular, que puede provocar ceguera
VIERNES, 4 de noviembre de 2022 (HealthDay News) — Un hallazgo sugiere que más estadounidenses que nunca presentan dificultades de visión a medida que envejecen, y los investigadores informan que casi 20 millones de adultos tienen una degeneración ma…
Learn MoreVision Is Vulnerable With Age: Here’s What to Look For
SUNDAY, Nov. 6, 2022 (HealthDay News) — Routine eye checks can help ensure seniors know if they’re developing any age-related vision issues.An expert from Baylor College of Medicine spells out what seniors need to know.”Don’t blame vision issues on j…
Learn MoreAge-Related Macular Degeneration Prevalence Remains High
FRIDAY, Nov. 4, 2022 (HealthDay News) — In 2019, roughly 18.34 million U.S. individuals (aged 40 years and older) were living with early-stage age-related macular degeneration (AMD) and 1.49 million were living with late-stage AMD, according to a stu…
Learn MoreAlmost 20 Million Older Americans Live With Sight-Robbing Macular Degeneration
FRIDAY, Nov. 4, 2022 (HealthDay News) — In a finding that suggests more Americans than ever are struggling with their sight as they get older, researchers report that nearly 20 million adults have age-related macular degeneration (AMD).Broken down, a…
Learn MoreAAO: One in Nine Patients With Wet AMD Skip Follow-Up
THURSDAY, Oct. 6, 2022 (HealthDay News) — One in nine people with wet age-related macular degeneration (AMD) are skipping appointments for sight-saving eye injections, according to a study presented at the annual meeting of the American Academy of Op…
Learn MoreUn método ‘escalonado’ quizá sea mejor para tratar a la enfermedad ocular diabética
VIERNES, 15 de julio de 2022 (HealthDay News) — Un medicamento de marca genérica para el edema macular diabético quizá resulte igual de efectivo en el tratamiento temprano que una alternativa más cara, lo que ahorraría potencialmente miles de dólares…
Learn More‘Stepped’ Approach to Treating Diabetic Eye Disease May Be Best
FRIDAY, July 15, 2022 (HealthDay News) — An off-brand medication for diabetic macular edema might prove just as effective in early treatment as its more expensive alternative, potentially saving patients thousands of dollars, new research suggests.Th…
Learn More